HivNCT03571555
Prospective Cohort Study of Adolescents Living With HIV and Their Caregivers Attending a Psychosocial Programme in Botswana
An observational study of Hiv, run by Royal Holloway University at 1 site in Botswana.
Trial summary
Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups… Read more about this study
- Who is it for?
- Ages 10 to 19 years
- Conditions the study is for
- Hiv
- What is being tested?
- Sentebale Psychosocial Programme
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 516 participants
- Where
- 1 siteBotswana
- Study dates
- 1 Mar 2019to 1 Jul 2020
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: 10-19 year olds living with HIV, new attenders to the Sentebale psychosocial programme Primary caregivers of 10-19 year olds living with HIV attending Sentebale, who are also attending Sentebale themselves
Who may be able to join
- Aged 10 to 19 years at the time of study enrolment
- Living with HIV and aware of HIV-positive status
- Able to give informed consent if 18 or 19 years
- Able to give informed assent if 10-17 years
- Presence of a caregiver to give caregiver consent if 10-17 years
- Attending Sentebale clubs with first attendance at club within previous month
Show all 9Show fewer
- Primary caregiver for a young person attending Sentebale
- Able to give informed consent
- Attending Sentebale clubs with first attendance within previous month
Who cannot join
- Previous camp attendance
- Any attendance at a different club/organisation providing a similar function
- Planning to leave the area served by the club within the next year
- CAREGIVERS
- Any attendance at a different club/organisation providing a similar function
- Planning to leave the area served by the club within the next year
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Prospective Cohort Study Evaluating a Psychosocial Programme for Adolescents Living With HIV and Their Caregivers in Botswana
Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups (clubs). There has been little quantitative evaluation of the effects of attending camps for young people and clubs (for children or caregivers), globally. This study aims to investigate whether a package of psychosocial support (camps and clubs) offered to young people living with HIV and their caregivers in Botswana by the Sentebale organisation, is associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up. In addition, the study will explore how the psychosocial programme is experienced by young people and their caregivers, and what the perceived impact is. The project as a whole will take place over three years. There will be an initial six month preparatory phase that will include the adaptation of self-report measures for the study context. Subsequently, two studies will be undertaken. The main study will involve a single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with young people and caregivers. The sub-study will involve a qualitative cross sectional design involving semi-structured interviews with young people and caregivers. Young people will be eligible to participate if they are aged 10 to 19 years at the time of study enrolment, are living with HIV and aware of HIV-positive status, have recently started attending the Sentebale programme, and are able to give informed assent/consent. We will aim to retain 175 young people (of 253 recruited) . We will also aim to retain 178 caregivers (of 263 recruited). The sample size for the sub-study will consist of ten young people and ten caregivers.
Read the detailed description
There are approximately two million young people between 10 and 19 years, living with HIV (UNAIDS, 2013). Many of this population have been living with HIV since birth. Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. They often have long histories of ART use with suboptimal regimens (Sohn \& Hazra, 2013) and rates of viral suppression are variable, often associated with poor ART adherence (Kim, Gerver, Fidler, \& Ward, 2014). Challenges to positive well-being in young people with PAH include some experiencing multiple caretaking transitions, loss due to parental illness or death, and other stressors associated with living with a chronic and stigmatised illness (e.g., hospitalisations, missed school and social opportunities, HIV disclosure challenges and pain). There is evidence of lower levels of wellbeing in young people living with PAH compared to their HIV unaffected peers (Mellins \& Malee, 2013).
Offering psychosocial interventions for young people living with HIV has the potential for enhancing well-being, HIV adjustment, ART adherence, self-esteem and increasing HIV knowledge and HIV disclosure. There are a small number of quantitative studies evaluating interventions to enhance antiretroviral adherence in young people with HIV (Shaw \& Amico, 2016) but few robust quantitative evaluations of psychosocial interventions to enhance well-being in this population (King, De Silva, Stein, \& Patel, 2009). There are no interventions on enhancing onward HIV disclosure in adolescents living with HIV (Evangeli \& Foster, 2014).
Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions and support groups. Regarding residential interventions, there is quantitative evidence in other chronic conditions of increased youth self-esteem after attendance (Odar, Canter, \& Roberts, 2013). There is also some qualitative literature on evaluating residential interventions (support camps) for young people living with HIV in the US (Gillard \& Allsop, 2016; Gillard, Witt, \& Watts, 2011; Pearson, Johnson, Simpson, \& Gallagher, 1997). Interviews with Camp attendees have revealed that this intervention can elicit a sense of belonging, enjoyment, escape, personal growth, being oneself, and caring connections, as well as increasing HIV knowledge, attitudes and skills. A recent quantitative evaluation of a residential intervention in the UK showed evidence for increases in HIV knowledge and pro-HIV disclosure attitudes and cognitions that were maintained at six month follow-up (Evangeli, Lut, \& Ely, 2016).
There is also some global evidence of positive benefits of support groups for children living with HIV, who report that groups provide a sense of belonging, normality, confidence and safety; supportive relationships; and a place to learn about treatment adherence and living healthily (Brothers, Harper, Fernandez, Hosek, \& Adolescent Trials Network for, 2014; Funck-Brentano et al., 2005; Midtbo, Shirima, Skovdal, \& Daniel, 2012; Mupambireyi, Bernays, Bwakura-Dangarembizi, \& Cowan, 2014; Muskat, Salter, Shindler, Porter, \& Bitnum, 2016). There has been little quantitative evaluation of the effects of attending support groups (for children or caregivers), although one pilot study using non-random allocation, showed some evidence of decreased worry about illness, less negative perception about treatment and greater rates of viral suppression in adolescents living with HIV (Funck-Brentano et al., 2005).
Sentebale is an organisation that has been providing residential interventions (camps) to adolescents living with HIV, and follow up support groups (clubs) for these adolescents and their caregivers, amongst other psychosocial interventions, in Lesotho for a number of years. Sentebale is now offering a similar package of psychosocial services to young people and caregivers in Botswana, partnering with Serious Fun Children's Network. The aims of Sentebale are to provide support that will enable young people to living healthy and hopeful lives, increase confidence, improve educational and occupational functioning, increase care and support, enhance HIV communication, increase caregiver support, reduce onward transmission, and increase remembering to take medication. We will evaluate the above psychosocial programme, given the need to investigate the psychosocial, behavioural and clinical outcomes of this type of intervention in high HIV prevalence contexts. Botswana has an estimated HIV prevalence of 6.6% in 15-19 year olds, and an estimated adult prevalence rate of 18.5%, and despite high levels of ART adherence, psychological difficulties in this population are common (Gupta et al., 2010).
Aims and objectives
This three year study aims to answer the following questions in a population of adolescents living with HIV and their caregivers:
- Is the package of support offered by Sentebale (camps for young people, clubs for young people and caregivers) associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up?
- How is the package of support experienced by young people and their caregivers, and what is the perceived impact for young people and their caregivers?
Study Design
- Main study - single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with 175 young people and 178 caregivers retained in the study (Study Aim 1).
- Sub-study - qualitative cross sectional design involving semi-structured interviews with 10 young people and 10 caregivers (Study Aim 2).
- Conditions
- Hiv
- Being tested
- Sentebale Psychosocial Programme
- Keywords
- HIV, perinatal, adolescent, camp, psychosocial
- Medical subject headings
- Acquired Immunodeficiency Syndrome, Muscle Cramp
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sentebale Psychosocial ProgrammeBehavioural
Residential interventions (camps) for the young people, and community based support (clubs) for the young people and the caregivers.
| Study group | Role | What they receive |
|---|---|---|
| Young people with perinatally acquired HIV | Residential interventions (camps) and community based support (clubs) Receives: Behavioral: Sentebale Psychosocial Programme | |
| Caregivers of young people with perinatally acquired HIV | Community based support (clubs) Receives: Behavioral: Sentebale Psychosocial Programme |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Life/Well-being (Young People)
The 17 item Pediatric Symptom Checklist (PSY-Y-17) will be used.
Minimum value 0, maximum 51. Higher scores, worse outcome.
Measured: One year
Secondary outcomes (18)
HIV Knowledge (Young People)
The Brief HIV Knowledge Questionnaire (Carey \& Schroder, 2002) and other measures (Aaro et al, 2011; Evangeli et al, 2016) will be adapted to produce a new measure of general HIV knowledge, transmission, medication and reproduction information.
Measured: One year
HIV Adjustment (Young People)
The 18 item Illness Cognition Questionnaire will be used (Evers et al., 2001).
Measured: One year
ART Adherence Behaviour (Young People)
The total score of the CASE adherence index (Mannheimer et al., 2006) will be used. Higher scores indicate higher self-reported ART adherence
Measured: One year
ART Adherence Attitudes (Young People)
The total score of 15 item antiretroviral medication attitudes scale (Viswanathan, Anderson, \& Thomas, 2005) will be used. Higher scores indicate more positive adherence attitudes.
Measured: One year
ART Adherence Self-efficacy (Young People)
The total score of the 12 item HIV medication self-efficacy scale (Erlen, Cha, Kim, Caruthers, \& Sereika, 2010) will be used. Higher scores indicated higher adherence self-efficacy.
Measured: One year
HIV Onward Disclosure Cognitions and Affect (Young People)
The 18 item Adolescent HIV Disclosure Cognitions and Affect Scale (Evangeli, 2017) will be used to assess attitudes towards sharing one's status, normative disclosure beliefs, disclosure affect and disclosure self-efficacy.
Measured: One year
HIV Onward Disclosure (Young People)
The 18 item Adolescent HIV Disclosure Cognitions and Affect Scale (Evangeli, 2017) will be used to assess attitudes towards sharing one's status, normative disclosure beliefs, disclosure affect and disclosure self-efficacy. The total score will be used. Higher scores indicate more pro-disclosure beliefs. An additional item assessed the young person's intention to share their status with others over the next year will be added.
HIV disclosure events will be assessed at baseline and follow-up through recording the frequency of new disclosures in last year (first hand or second hand) and the proportion in one's social network disclosed to (Serovich, Craft, \& Reed, 2012; Serovich, Craft, \& Yoon, 2007).
Measured: One year
HIV Onward Disclosure Behaviour (Young People)
HIV disclosure events will be assessed at baseline and follow-up through recording the frequency of new disclosures in last year (first hand or second hand) and the proportion in one's social network disclosed to (Serovich, Craft, \& Reed, 2012; Serovich, Craft, \& Yoon, 2007).
Measured: One year
HIV Communication Behaviour (Young People)
The frequency of HIV communication will be measured.
Measured: One year
HIV Communication Beliefs (Young People)
The Adolescent HIV Communication Belief Scale (Evangeli, in press) will be used. An additional item will assess intention to communicate about HIV.
Measured: One year
Self-esteem (Young People)
The 10 item Rosenberg global self-esteem measure will be used (Rosenberg, 1965).
Measured: One year
HIV Stigma (Young People)
The total score of the 10 item Stigma Scale - Revised (Wright, Naar-King, Lam, Templin, \& Frey, 2007) will be used. Higher scores indicate more HIV stigma
Measured: One year
Social Support (Young People)
The total score of the 11 item Child and Adolescent Social Support Scale (Malecki \& Demaray, 2002) will be used. Higher scores indicate greater social support
Measured: One year
Hope(Young People)
The total score of the 5 item Botswana Adolescent Beliefs about the Future Scale will be used. Higher scores indicate greater hope.
Measured: One year
HIV Knowledge (Caregivers)
The HIV-KQ-18 measure (Carey \& Schroder, 2002) will be adapted for use in Botswana
Measured: One year
ART Adherence Attitudes (Caregivers)
The 15 item antiretroviral medication attitudes scale (Viswanathan et al., 2005) will be used. The measure will be adapted for use with Batswana caregivers.
Measured: One year
HIV Stigma (Caregivers)
The total score of the 9 item HIV Stigma Scale will be used (Kalichman et al., 2005). Higher scores indicate higher levels of HIV stigma.
Measured: One year
Viral Suppression (Young People)
Most recent viral load in the six months before the baseline assessment and most recent viral load in the six months after the follow-up period, will be collected from participants' clinical records.
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2018
- Study start1 Mar 2019
- Primary completion1 Jul 2020
- Study completion1 Jul 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for HivStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 516 participants (actual)
Sponsor and investigators
- Lead sponsor
- Royal Holloway University
- Sponsor type
- University, hospital or other
- Collaborators
- African Comprehensive HIV/AIDS Partnership, Sentebale
- Responsible party
- Principal investigator, Dr. Michael Evangeli, Royal Holloway University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03571555
- Sponsor's protocol ID
- Sentebale
- Status last verified
- Mar 2021
- First submitted
- 31 May 2018
- Last updated
- 26 Apr 2021
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymised electronic data from the study will be transferred to a data repository (eg.,Figshare or RHUL Research Data Archive) at the end of the study.
Study at a glance
From the registry record, last updated by the sponsor on 26 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Cohort Study Evaluating a Psychosocial Programme for Adolescents Living With HIV and Their Caregivers in Botswana
- ClinicalTrials.gov ID
- NCT03571555
- Acronym / sponsor ID
- Sentebale
- Conditions
- Hiv
- Keywords
- HIV, perinatal, adolescent, camp, psychosocial
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 516 participants (actual)
- Lead sponsor
- Royal Holloway UniversityUniversity, hospital or other
- Collaborators
- African Comprehensive HIV/AIDS Partnership, Sentebale
- Study start
- 1 Mar 2019 (actual)
- Primary completion
- 1 Jul 2020 (actual)
- Study completion
- 1 Jul 2020 (actual)
- First posted
- 27 Jun 2018 (actual)
- Results
- Posted 26 Apr 2021
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups (clubs). There has been little quantitative evaluation of the effects of attending camps for young people and clubs (for children or caregivers), globally. This study aims to investigate whether a package of psychosocial support (camps and clubs) offered to young people living with HIV and their caregivers in Botswana by the Sentebale organisation, is associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up. In addition, the study will explore how the psychosocial programme is experienced by young people and their caregivers, and what the perceived impact is. The project as a whole will take place over three years. There will be an initial six month preparatory phase that will include the adaptation of self-report measures for the study context. Subsequently, two studies will be undertaken. The main study will involve a single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with young people and caregivers. The sub-study will involve a qualitative cross sectional design involving semi-structured interviews with young people and caregivers. Young people will be eligible to participate if they are aged 10 to 19 years at the time of study enrolment, are living with HIV and aware of HIV-positive status, have recently started attending the Sentebale programme, and are able to give informed assent/consent. We will aim to retain 175 young people (of 253 recruited) . We will also aim to retain 178 caregivers (of 263 recruited). The sample size for the sub-study will consist of ten young people and ten caregivers.
Detailed description
There are approximately two million young people between 10 and 19 years, living with HIV (UNAIDS, 2013). Many of this population have been living with HIV since birth. Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. They often have long histories of ART use with suboptimal regimens (Sohn \& Hazra, 2013) and rates of viral suppression are variable, often associated with poor ART adherence (Kim, Gerver, Fidler, \& Ward, 2014). Challenges to positive well-being in young people with PAH include some experiencing multiple caretaking transitions, loss due to parental illness or death, and other stressors associated with living with a chronic and stigmatised illness (e.g., hospitalisations, missed school and social opportunities, HIV disclosure challenges and pain). There is evidence of lower levels of wellbeing in young people living with PAH compared to their HIV unaffected peers (Mellins \& Malee, 2013).
Offering psychosocial interventions for young people living with HIV has the potential for enhancing well-being, HIV adjustment, ART adherence, self-esteem and increasing HIV knowledge and HIV disclosure. There are a small number of quantitative studies evaluating interventions to enhance antiretroviral adherence in young people with HIV (Shaw \& Amico, 2016) but few robust quantitative evaluations of psychosocial interventions to enhance well-being in this population (King, De Silva, Stein, \& Patel, 2009). There are no interventions on enhancing onward HIV disclosure in adolescents living with HIV (Evangeli \& Foster, 2014).
Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions and support groups. Regarding residential interventions, there is quantitative evidence in other chronic conditions of increased youth self-esteem after attendance (Odar, Canter, \& Roberts, 2013). There is also some qualitative literature on evaluating residential interventions (support camps) for young people living with HIV in the US (Gillard \& Allsop, 2016; Gillard, Witt, \& Watts, 2011; Pearson, Johnson, Simpson, \& Gallagher, 1997). Interviews with Camp attendees have revealed that this intervention can elicit a sense of belonging, enjoyment, escape, personal growth, being oneself, and caring connections, as well as increasing HIV knowledge, attitudes and skills. A recent quantitative evaluation of a residential intervention in the UK showed evidence for increases in HIV knowledge and pro-HIV disclosure attitudes and cognitions that were maintained at six month follow-up (Evangeli, Lut, \& Ely, 2016).
There is also some global evidence of positive benefits of support groups for children living with HIV, who report that groups provide a sense of belonging, normality, confidence and safety; supportive relationships; and a place to learn about treatment adherence and living healthily (Brothers, Harper, Fernandez, Hosek, \& Adolescent Trials Network for, 2014; Funck-Brentano et al., 2005; Midtbo, Shirima, Skovdal, \& Daniel, 2012; Mupambireyi, Bernays, Bwakura-Dangarembizi, \& Cowan, 2014; Muskat, Salter, Shindler, Porter, \& Bitnum, 2016). There has been little quantitative evaluation of the effects of attending support groups (for children or caregivers), although one pilot study using non-random allocation, showed some evidence of decreased worry about illness, less negative perception about treatment and greater rates of viral suppression in adolescents living with HIV (Funck-Brentano et al., 2005).
Sentebale is an organisation that has been providing residential interventions (camps) to adolescents living with HIV, and follow up support groups (clubs) for these adolescents and their caregivers, amongst other psychosocial interventions, in Lesotho for a number of years. Sentebale is now offering a similar package of psychosocial services to young people and caregivers in Botswana, partnering with Serious Fun Children's Network. The aims of Sentebale are to provide support that will enable young people to living healthy and hopeful lives, increase confidence, improve educational and occupational functioning, increase care and support, enhance HIV communication, increase caregiver support, reduce onward transmission, and increase remembering to take medication. We will evaluate the above psychosocial programme, given the need to investigate the psychosocial, behavioural and clinical outcomes of this type of intervention in high HIV prevalence contexts. Botswana has an estimated HIV prevalence of 6.6% in 15-19 year olds, and an estimated adult prevalence rate of 18.5%, and despite high levels of ART adherence, psychological difficulties in this population are common (Gupta et al., 2010).
Aims and objectives
This three year study aims to answer the following questions in a population of adolescents living with HIV and their caregivers:
- Is the package of support offered by Sentebale (camps for young people, clubs for young people and caregivers) associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up?
- How is the package of support experienced by young people and their caregivers, and what is the perceived impact for young people and their caregivers?
Study Design
- Main study - single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with 175 young people and 178 caregivers retained in the study (Study Aim 1).
- Sub-study - qualitative cross sectional design involving semi-structured interviews with 10 young people and 10 caregivers (Study Aim 2).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Young people with perinatally acquired HIV | – | Behavioral: Sentebale Psychosocial ProgrammeResidential interventions (camps) and community based support (clubs) |
| Caregivers of young people with perinatally acquired HIV | – | Behavioral: Sentebale Psychosocial ProgrammeCommunity based support (clubs) |
Who may qualify
- Ages
- 10 to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- 10-19 year olds living with HIV, new attenders to the Sentebale psychosocial programme Primary caregivers of 10-19 year olds living with HIV attending Sentebale, who are also attending Sentebale themselves
Key inclusion criteria (9 listed)
- Aged 10 to 19 years at the time of study enrolment
- Living with HIV and aware of HIV-positive status
- Able to give informed consent if 18 or 19 years
- Able to give informed assent if 10-17 years
- Presence of a caregiver to give caregiver consent if 10-17 years
Key exclusion criteria (6 listed)
- Previous camp attendance
- Any attendance at a different club/organisation providing a similar function
- Planning to leave the area served by the club within the next year
- CAREGIVERS
- Any attendance at a different club/organisation providing a similar function
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sentebale Psychosocial ProgrammeResidential interventions (camps) for the young people, and community based support (clubs) for the young people and the caregivers. | Behavioural | Caregivers of young people with perinatally acquired HIV, Young people with perinatally acquired HIV |
Primary outcome
Quality of Life/Well-being (Young People)
Time frame: One year
The 17 item Pediatric Symptom Checklist (PSY-Y-17) will be used. Minimum value 0, maximum 51. Higher scores, worse outcome.
18 secondary outcomes
HIV Knowledge (Young People)
Time frame: One year
HIV Adjustment (Young People)
Time frame: One year
ART Adherence Behaviour (Young People)
Time frame: One year
ART Adherence Attitudes (Young People)
Time frame: One year
ART Adherence Self-efficacy (Young People)
Time frame: One year
HIV Onward Disclosure Cognitions and Affect (Young People)
Time frame: One year
HIV Onward Disclosure (Young People)
Time frame: One year
HIV Onward Disclosure Behaviour (Young People)
Time frame: One year
HIV Communication Behaviour (Young People)
Time frame: One year
HIV Communication Beliefs (Young People)
Time frame: One year
Self-esteem (Young People)
Time frame: One year
HIV Stigma (Young People)
Time frame: One year
Social Support (Young People)
Time frame: One year
Hope(Young People)
Time frame: One year
HIV Knowledge (Caregivers)
Time frame: One year
ART Adherence Attitudes (Caregivers)
Time frame: One year
HIV Stigma (Caregivers)
Time frame: One year
Viral Suppression (Young People)
Time frame: one year
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Apr 2021.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: Yes. Anonymised electronic data from the study will be transferred to a data repository (eg.,Figshare or RHUL Research Data Archive) at the end of the study.
Related trials for Hiv
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hiv, run by Royal Holloway University at 1 site in Botswana.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Botswana. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 26 Apr 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Life/Well-being (Young People) (time frame: One year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2021.